China Universal Asset Management Company’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-21,225
| Closed | -$843K | – | 521 |
|
|
2026
Q1 | $843K | Buy |
21,225
+5,504
| +35% | +$141K | 0.06% | 212 |
|
|
2025
Q4 | $393K | Sell |
15,721
-1,095
| -7% | -$27.7K | 0.03% | 281 |
|
|
2025
Q3 | $408K | Sell |
16,816
-2,365
| -12% | -$42K | 0.03% | 266 |
|
|
2025
Q2 | $252K | Buy |
19,181
+870
| +5% | +$11K | 0.02% | 291 |
|
|
2025
Q1 | $263K | Sell |
18,311
-598
| -3% | -$9.79K | 0.02% | 291 |
|
|
2024
Q4 | $317K | Buy |
18,909
+5,316
| +39% | +$88.1K | 0.03% | 293 |
|
|
2024
Q3 | $217K | Buy |
13,593
+6,785
| +100% | +$83.1K | 0.02% | 294 |
|
|
2024
Q2 | $61.5K | Sell |
6,808
-4,009
| -37% | -$38K | 0.01% | 344 |
|
|
2024
Q1 | $122K | Buy |
10,817
+4,423
| +69% | +$41.9K | 0.02% | 350 |
|
|
2023
Q4 | $50.9K | Buy |
6,394
+5,037
| +371% | +$33.8K | 0.01% | 369 |
|
|
2023
Q3 | $8.78K | Buy |
1,357
+666
| +96% | +$4.56K | ﹤0.01% | 355 |
|
|
2023
Q2 | $4.28K | Sell |
691
-21
| -3% | -$100 | ﹤0.01% | 384 |
|
|
2023
Q1 | $2.74K | Buy |
712
+179
| +34% | +$655 | ﹤0.01% | 422 |
|
|
2022
Q4 | $1.65K | Buy |
533
+52
| +11% | +$193 | ﹤0.01% | 383 |
|
|
2022
Q3 | $2K | Buy |
+481
| New | +$2.2K | ﹤0.01% | 346 |
|
China Universal Asset Management Company's CNTA Position: Q2 2026 in Review
China Universal Asset Management Company sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 21,225 shares — an estimated $843K sold.
China Universal Asset Management Company first reported a position in CNTA in Q3 2022 and held it in 15 quarters. The position peaked at $843K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.
- China Universal Asset Management Company reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- China Universal Asset Management Company sold 21,225 Centessa Pharmaceuticals shares in Q2 2026, an estimated $843K.
- China Universal Asset Management Company first reported a position in Centessa Pharmaceuticals in Q3 2022 and held it in 15 quarters.
- China Universal Asset Management Company's Centessa Pharmaceuticals position peaked at $843K in Q1 2026.
- 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.